Valuation : Captor Therapeutics Spolka Akcyjna

Market Cap 473M 127M 109M 104M 93.94M 176M 12.14B 177M 1.23B 6.17B 477M 467M 19.51B P/E 2026 *
24.3x
P/E 2027 * -11.6x
Enterprise Value 401M 108M 92.69M 87.76M 79.55M 149M 10.28B 150M 1.04B 5.23B 404M 395M 16.52B EV / Sales 2026 *
7.07x
EV / Sales 2027 * 44.1x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 week+4.49%
Current month+3.62%
1 month+1.36%
3 months-3.25%
6 months-14.76%
Current year+3.47%
1 week 69.6
Extreme 69.6
74.8
1 month 68.3
Extreme 68.3
74.8
Current year 67.2
Extreme 67.2
89.2
1 year 34.6
Extreme 34.6
89.2
3 years 31.2
Extreme 31.2
132
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 31/05/2025
Director of Finance/CFO - 01/02/2025
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Chairman 54 30/06/2022
Director/Board Member 74 30/06/2022
Director/Board Member - 30/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
26/02/26 Buy 1,100 0.0198%
12/12/25 Free

Chairman

360,074 6.5128%
12/12/25 Don

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.49%+105.23%-37.92% 127M
-0.71%-6.35%-4.87%+9.03% 45.48B
+0.21%-2.98%+340.68%+519.93% 43.69B
+1.74%-2.24%+37.28%+21.57% 43.09B
+1.38%-3.28%+3.23%+65.60% 39.4B
-1.44%-5.26%+8.78%+36.85% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+18.07%+110.32% 16.4B
-0.31%-2.78%+10.47%+30.49% 14.24B
+1.93%-3.55%+74.20%+39.37% 13.28B
Average +0.44%-2.77%+65.90%+88.36% 26.49B
Weighted average by Cap. +0.41%-3.66%+73.18%+123.48%

Financials

2026 *2027 *
Net sales 56.7M 15.22M 13.11M 12.41M 11.25M 21.11M 1.45B 21.22M 147M 740M 57.15M 55.9M 2.34B 10M 2.68M 2.31M 2.19M 1.98M 3.72M 256M 3.74M 26M 130M 10.08M 9.86M 412M
Net income -3M -805K -694K -657K -595K -1.12M -76.92M -1.12M -7.8M -39.13M -3.02M -2.96M -124M -41M -11M -9.48M -8.98M -8.14M -15.27M -1.05B -15.34M -107M -535M -41.33M -40.42M -1.69B
Net Debt -72.5M -19.46M -16.76M -15.87M -14.39M -26.99M -1.86B -27.13M -189M -946M -73.08M -71.47M -2.99B -32M -8.59M -7.4M -7.01M -6.35M -11.91M -820M -11.97M -83.22M -417M -32.25M -31.55M -1.32B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
-
Date Price Change Volume
11/09/26 PLN 74.50 0.00% 5,073
10/09/26 PLN 74.50 +4.05% 2,146
09/09/26 PLN 71.60 -1.51% 2,182
08/09/26 PLN 72.70 +3.12% 11,472
07/09/26 PLN 70.50 -1.12% 413
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
74.50PLN
Average target price
86.83PLN
Spread / Average Target
+16.55%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!